Skip to content

Design Therapeutics, Inc. DSGN Total Current Assets

Total Current Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
$4.22B+29.1%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$466.45M-15.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$2.45B+31.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.02B+48.1%
Vor Biopharma logo
Vor BiopharmaVOR
$500.78M+672%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$282.25M+134%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$860.66M+305%
Enterprise value$850.62M+324%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Design Therapeutics, Inc.'s total current assets?
Design Therapeutics, Inc. (DSGN) reported total current assets of $227.05M in Q1 2026.
How has Design Therapeutics, Inc.'s total current assets changed year-over-year?
Design Therapeutics, Inc.'s total current assets decreased by 2.8% year-over-year, from $233.64M to $227.05M.
What is the long-term trend for Design Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total current assets has grown at a 43.9% compound annual growth rate (CAGR), from $36.23M to $223.78M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.